RESEARCHER PROFILE
Jonathan D. Smith
← Back to Case Western Reserve University
J
Case Western Reserve University
Jonathan D. Smith works in Cholesterol and Lipid Metabolism, Atherosclerosis and Cardiovascular Diseases, Lipoproteins and Cardiovascular Health, Cardiac electrophysiology and arrhythmias, Atrial Fibrillation Management and Outcomes. Recorded institutional associations include Cleveland Clinic, Lund University, AbbVie (United States).
519Publications
37,007Citations
83H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 · 5,576 citationsIntestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
2013 · 4,372 citationsSevere hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
1992 · 2,261 citationsTargeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
2000 · 1,044 citationsApolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides
1996 · 887 citationsApoE Promotes the Proteolytic Degradation of Aβ
2008 · 874 citationsMulti-ethnic genome-wide association study for atrial fibrillation
2018 · 771 citationsApolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
2004 · 737 citationsDecreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.
1995 · 724 citationsMeta-analysis identifies six new susceptibility loci for atrial fibrillation
2012 · 599 citationsγ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
2014 · 545 citationsCommon variants in KCNN3 are associated with lone atrial fibrillation
2010 · 485 citationsGenome-wide association study of PR interval
2010 · 438 citationsHigh-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
2012 · 393 citationsAn abundant dysfunctional apolipoprotein A1 in human atheroma
2014 · 364 citationsT and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
1997 · 346 citationsVineland Adaptive Behavior Scales
2012 · 346 citationsLarge-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation
2017 · 343 citationsAlcohol Consumption Raises HDL Cholesterol Levels by Increasing the Transport Rate of Apolipoproteins A-I and A-II
2000 · 321 citationsHDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P 1 to limit vascular inflammation
2015 · 314 citationsParadoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
2013 · 303 citationsCommon genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.
1995 · 278 citationsCharacterization of Clone 13, a Naturally Attenuated Avirulent Isolate of Rift Valley Fever Virus, which is Altered in the Small Segment
1995 · 273 citationsLipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides
2000 · 272 citationsMyeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
2013 · 268 citations
